Template:BV Metronidazole Adult: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
Ostermayer (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
;500mg PO q12 x 7 days | ;500mg PO q12 x 7 days | ||
====Pregnancy==== | ====Pregnancy==== | ||
*250mg PO q8h x 7 days in pregnant patients<ref name="cdc | *Alternative: 250mg PO q8h x 7 days in pregnant patients<ref name="cdc">CDC Pregnancy BV Treatment Guidelines.[http://www.cdc.gov/std/treatment/2010/vaginal-discharge.htm#a1 cdc.gov]</ref> | ||
* Multiple studies have not demonstrated teratogenicity from metronidazole use<ref name="cdc | *2g PO x 1 is also acceptable in pregnancy<ref "cdc"></ref> | ||
* Multiple studies have not demonstrated teratogenicity from metronidazole use<ref name="cdc"></ref> | |||
====Prophylaxis ([[Sexual Assault]])==== | ====Prophylaxis ([[Sexual Assault]])==== | ||
*2 g PO x 1 | *2 g PO x 1 | ||
Revision as of 01:38, 18 June 2014
- 500mg PO q12 x 7 days
Pregnancy
- Alternative: 250mg PO q8h x 7 days in pregnant patients[1]
- 2g PO x 1 is also acceptable in pregnancyCite error: Invalid
<ref>tag; refs with no name must have content - Multiple studies have not demonstrated teratogenicity from metronidazole use[1]
Prophylaxis (Sexual Assault)
- 2 g PO x 1